For research use only. Not for therapeutic Use.
Naringenin is a citrus-<wbr></wbr>derived flavonoid that inhibits CYP3A4 activity in human liver microsomes (IC<sub>50</sub>s = 139-<wbr></wbr>188 μM). At 100 mg/kg/day, naringenin selectively inhibits the transcription of Smad3 and directly down-<wbr></wbr>regulates TGF-<wbr></wbr>β1, significantly reducing lung metastasis in mice with bleomycin-<wbr></wbr>induced pulmonary fibrosis. Naringenin demonstrates both lipid lowering and insulin-<wbr></wbr>like properties in low-<wbr></wbr>density lipoprotein (LDL) receptor-<wbr></wbr>deficient mice fed a Western diet containing 1-<wbr></wbr>3% naringenin by correcting VLDL overproduction, ameliorating hepatic steatosis, and attenuating dyslipidemia without affecting caloric intake or fat absorption.
Catalog Number | R004641 |
CAS Number | 67604-48-2 |
Synonyms | 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (R,S)-Naringenin; (+/-)-5,7,4’-Trihydroxyflavanone; 5,7,4’-Trihydroxyflavanone; |
Molecular Formula | C15H12O5 |
Purity | ≥95% |
Target | Potassium Channel |
Storage | -20°C |
IUPAC Name | 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one |
InChI | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2 |
InChIKey | FTVWIRXFELQLPI-UHFFFAOYSA-N |
SMILES | C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O |